Refine by
Clinical Study Articles & Analysis
1,611 news found
This modular platform has integrated cutting-edge micro-fabrication equipment, advanced material engineering, and analytical validation systems to help biotechnology companies and research institutions to seamlessly scale microneedle therapies from bench-top prototypes to clinical-grade pilot production. Microneedles (MNs) are micrometre-scale needles that range in height from 25 ...
June 9, 2026, Austin, TX — Zetagen Therapeutics, a clinical-stage biopharmaceutical company focused on therapies for primary and metastatic breast cancer, today reported preliminary topline results from its Phase 2a open-label study evaluating ZetaMet (Zeta BC 003) in metastatic breast cancer with lytic bone lesions. ...
Corify Care today announced a clinical milestone with two studies published in Heart Rhythm and Europace, validating its 4-D global cardiac mapping technology for atrial and ventricular arrhythmias in a single beat.Compared with conventional mapping, which often requires rhythm induction or dependence on pre-procedural imaging, the ACORYS mapping system captures ...
The ACORYS® System provides instant, whole-heart functional insight to support faster, safer, and more predictable ablation procedures.Designed to complement modern EP workflows, ACORYS enables real-time panoramic mapping of complex arrhythmia mechanisms, allowing clinical teams to gain immediate functional insight without pre-procedural imaging or induction of unstable ...
Kerecis will highlight its intact fish-skin platform and new clinical data at SAWC Spring 2026, taking place April 8–11 at the Charlotte Convention Center. ...
ByKerecis
RTsafe, a leading medical technology company specialising in quality assurance (QA) solutions for radiation therapy, and Icon Group (Icon), a leading integrated cancer care provider with a global reach across Australia, New Zealand, ASEAN, Mainland China and the United Kingdom, today announced the purchase of two RTsafe PRIME phantoms. These are the first PRIME phantoms to be installed in ...
ByRTsafe
Significant advances have been made in recent years in the study of cancer-associated fibroblasts (CAFs). These cells regulate cancer metastasis by synthesizing and remodelling the extracellular matrix (ECM), as well as secreting growth factors. They also influence angiogenesis, tumour mechanical properties, drug access and therapeutic response. Recent studies ...
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, under Florida’s SB 1768, ...
Targeted opt-in email provides company news, clinical developments, and financing updates: email: [email protected], Investor platforms and exchanges (https://www.otcmarkets.com/stock/HMTXF/overview) are designed to increase Hemostemix’s visibility, providing due diligence level information that retail and institutional audiences seek about our Company’s ...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Patrick Serfass, Executive Director of the American Biogas Council, recently sat down with the Recyclist Podcast to reveal how the One Big Beautiful Bill Act supports Biogas and how advocacy is pushing the industry forward. The ABC were among the industry groups lobbying in favor of the bill. Following its passing on July 4th, 2025, Serfass released a statement saying, in part, “The Act ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
BOC Sciences hosts Prof. Gang Zheng in a groundbreaking webinar on theranostic lipid nanoparticles for cancer medicine BOC Sciences announces an upcoming webinar featuring Prof. Gang Zheng, a senior scientist in nanomedicine and cancer theranostics. The webinar, titled "Theranostic Lipid Nanoparticles for Cancer Medicine," will take place this July, offering researchers and industry ...
CD Bioparticles’ new product line of Exosome Identification (WB Markers) helps researchers advance exosome studies, whether it‘s to understand fundamental biological processes or to develop new diagnostic and therapeutic strategies. ...
Tariff escalation strikes not only the industrial chain but also weighs heavily on the frontlines of life and health. Mass spectrometers, flow cytometers, and other core instruments have long been monopolized by foreign brands, limiting domestic applications. As China-U.S. trade tensions continue to intensify, life sciences have become a key battleground in the technological rivalry. Critical ...
Ghrelin, widely recognized as the hunger hormone, is now under the spotlight for its role in mental health. Recent studies suggest that this metabolic signal may influence mood, especially in individuals with major depressive disorder (MDD). ...
Summary Dentists and surgeons devote their professional lives to improving patient health, often engaging in complex procedures that require precision, concentration, and prolonged static or awkward positioning. However, inadequate ergonomics can result in chronic pain, musculoskeletal disorders (MSDs), fatigue, and shortened careers, with studies indicating that up to 80% of these professionals ...
Changsha, China – Hunan Huateng Pharmaceutical Co., Ltd. (Huateng Pharma), a global leader in the development and production of high-quality PEG derivatives, is pleased to announce that its mPEG-pALD (20K) has successfully completed its Drug Master File (DMF) filing with the U.S. Food and Drug Administration (FDA), under DMF No. 040600. This achievement highlights Huateng Pharma’s ...
However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to provide consistent results in support of analytical studies and assays. Since its inception, CD Bioparticles has been committed to developing and providing cutting-edge technologies to advance drug discovery and ...
Endotoxin free silver nanoparticles are characterized by high purity and low endotoxin levels, ideal for use in in vivo studies and clinical trials with a low risk of adverse effects. CD Bioparticles provides a range of endotoxin free silver nanoparticles with sizes varying from 10 nm to 100 nm. ...